EAGLE DX Trademark

Trademark Overview


On Thursday, January 20, 2022, a trademark application was filed for EAGLE DX with the United States Patent and Trademark Office. The USPTO has given the EAGLE DX trademark a serial number of 97230179. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, May 19, 2023. This trademark is owned by Sports Drug Testing Laboratory, Inc.. The EAGLE DX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Blood testing services; biomedical testing
eagle dx

General Information


Serial Number97230179
Word MarkEAGLE DX
Filing DateThursday, January 20, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, May 19, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBlood testing services; biomedical testing

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 26, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSports Drug Testing Laboratory, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth Jordan, UT 84095

Trademark Events


Event DateEvent Description
Friday, May 19, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, May 19, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, May 19, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, November 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 4, 2022NON-FINAL ACTION E-MAILED
Friday, November 4, 2022NON-FINAL ACTION WRITTEN
Friday, October 28, 2022ASSIGNED TO EXAMINER
Wednesday, January 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED